Analysts Offer Insights on Healthcare Companies: Rhythm Pharmaceuticals (RYTM), Beam Therapeutics (BEAM) and Glaukos (GKOS)
Glaukos Analyst Ratings
Truist Securities Reiterates Buy on Glaukos, Maintains $110 Price Target
Truist Financial Reaffirms Their Buy Rating on Glaukos (GKOS)
Glaukos Corporation: Hold Rating With Cautious Optimism Amidst IDose Launch and Reimbursement Uncertainties
Piper Sandler Sticks to Its Buy Rating for Glaukos (GKOS)
Buy Rating for Glaukos: A Comprehensive Analysis of Growth Drivers and Financial Stability
Glaukos Analyst Ratings
Analysts Offer Insights on Healthcare Companies: GeneDx Holdings (WGS) and Glaukos (GKOS)
Piper Sandler Gives a Buy Rating to Glaukos (GKOS)
Analysts' Top Healthcare Picks: Ionis Pharmaceuticals (IONS), Glaukos (GKOS)
Glaukos Analyst Ratings
Analysts' Opinions Are Mixed on These Healthcare Stocks: Stryker (SYK), BioMarin Pharmaceutical (BMRN) and Glaukos (GKOS)
Analysts Are Bullish on These Healthcare Stocks: Icon (ICLR), Glaukos (GKOS)
BTIG Remains a Buy on Glaukos (GKOS)
Glaukos Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Masimo (MASI), Gracell Biotechnologies (GRCL) and Glaukos (GKOS)
Truist Securities Maintains Buy on Glaukos, Raises Price Target to $100
Glaukos Analyst Ratings
Analysts Have Conflicting Sentiments on These Healthcare Companies: Alnylam Pharma (ALNY), Ionis Pharmaceuticals (IONS) and Glaukos (GKOS)
No Data